FTC sues AbbVie over “baseless patent infringement lawsuits”
The Federal Trade Commission (FTC) has filed a complaint in federal district court charging pharmaceutical companies AbbVie and Besins Healthcare with illegally blocking US consumers’ access to lower-cost versions of the blockbuster drug AndroGel
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
